Clinical Trial Update: The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating a conditioning regimen (thiotepa, fludarabine, cytarabine, busulfan) with G-CSF support for single unrelated umbilica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• CYTARABINE (CYTARABINE)
• Filgrastim (filgrastim)
• Fludarabine (Fludarabine)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hematologic Malignancies | Phase 2 | Status: NOT_YET_RECRUITING